Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    Open Studies | "Cerebellar Diseases"
Show Display Options
Rank Status Study
1 Recruiting Emotional Communication Disorders in Cerebellar Disease
Condition: Cerebellar Diseases
Interventions: Behavioral: Testing of emotional communication ability;   Procedure: magnetic resonance imaging (MRI) of the brain
2 Recruiting Gaze Holding in Cerebellar Patients
Conditions: Gaze Holding in Humans;   Rebound in Humans
Intervention: Other: visual stimulus to follow
3 Recruiting An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373;   Drug: Placebo
4 Recruiting The EUROSCA Natural History Study
Condition: Spinocerebellar Ataxia
Intervention:
5 Recruiting Trial in Adult Subjects With Spinocerebellar Ataxia
Conditions: Spinocerebellar Ataxias;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 10
Interventions: Drug: BHV-4157;   Drug: Placebo Comparator
6 Recruiting Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene
Condition: Cerebellar Ataxia
Interventions: Other: Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait;   Other: walking track GAITRite,manual dynamometer, and treadmill
7 Recruiting Augmenting Balance in Individuals With Cerebellar Ataxias
Condition: Cerebellar Ataxia
Intervention: Behavioral: Sensory Augmentation
8 Recruiting A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiography (ECHO);   Procedure: Cardiac-related blood studies
9 Recruiting Natural History of Spinocerebellar Ataxia Type 7 (SCA7)
Condition: Spinocerebellar Ataxia
Intervention:
10 Recruiting Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Condition: Ataxia-Telangiectasia
Interventions: Drug: Metformin;   Drug: Pioglitazone
11 Recruiting Rosuvastatin (Crestor) in Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Rosuvastatin
12 Recruiting Sporadic Degenerative Ataxia With Adult Onset: Natural History Study
Condition: Late Onset Sporadic Cerebellar Ataxia
Intervention:
13 Recruiting (+) Epicatechin to Treat Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: (+)-Epicatechin
14 Recruiting Efficacy and Safety Study of Stemchymal® in Polyglutamine Spinocerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Biological: Stemchymal®;   Procedure: Excipients
15 Recruiting Biomarkers in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention:
16 Recruiting Methylprednisolone Treatment of Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Methylprednisolone
17 Recruiting Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiogram (ECHO);   Procedure: Cardiac-related blood studies
18 Recruiting An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
Condition: Spinocerebellar Ataxias
Intervention: Drug: Intravenous Immune Globulin (IVIG)
19 Recruiting RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
Condition: Friedreich Ataxia
Interventions: Drug: Omaveloxolone Capsules, 2.5 mg;   Drug: Omaveloxolone Capsules, 5 mg;   Drug: Omaveloxolone Capsules, 10 mg;   Drug: Placebo;   Drug: Omaveloxolone Capsules, 20 mg;   Drug: Omaveloxolone Capsules, TBD mg;   Drug: Omaveloxolone Capsules, 40 mg;   Drug: Omaveloxolone Capsules, 80 mg;   Drug: Omaveloxolone Capsules, 160 mg;   Drug: Omaveloxolone Capsules, 300 mg
20 Recruiting Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia
Condition: Ataxia-Telangiectasia (A-T)
Interventions: Other: with gene correction;   Other: without gene correction

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.